TELA BIO INC (TELA)

US8723811084 - Common Stock

2.91  +0.03 (+1.04%)

After market: 2.91 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
29.46M
61.78%
41.42M
40.60%
58.453M
41.12%
76.214M
30.39%
95.658M
25.51%
118.98M
24.38%
153.04M
28.63%
192.48M
25.77%
EBITDA
YoY % growth
-28.92M
-16.80%
-37.83M
-30.81%
-43.267M
-14.37%
-32.299M
25.35%
-14.824M
54.11%
-684.42K
95.38%
24.496M
3,679.09%
51.151M
108.81%
EBIT
YoY % growth
-29.45M
-16.50%
-39.01M
-32.46%
-44.075M
-12.98%
-32.159M
27.04%
-20.985M
34.75%
-7.008M
66.60%
14.27M
303.62%
38.527M
169.99%
Operating Margin
-99.97%-94.18%-75.40%-42.20%-21.94%-5.89%9.32%20.02%
EPS
YoY % growth
-2.29
-2.69%
-2.70
-17.90%
-2.07
23.33%
-1.38
33.46%
-0.66
52.25%
-0.25
61.58%
0.30
217.05%
0.83
179.31%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.23
57.12%
-0.20
12.63%
-0.17
67.40%
-0.17
59.81%
-0.13
43.56%
-0.14
27.92%
-0.08
49.49%
-0.10
43.40%
-0.05
62.62%
Revenue
Q2Q % growth
23.634M
39.04%
21.586M
30.01%
22.812M
41.77%
23.972M
26.45%
27.322M
15.60%
26.566M
23.07%
28.433M
24.64%
30.402M
26.82%
35.168M
28.72%
EBITDA
Q2Q % growth
-4.522M
60.58%
-4.077M
66.51%
-3.194M
71.19%
-3.405M
60.50%
-2.368M
47.62%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-5.931M
51.70%
-7.304M
41.13%
-5.785M
50.00%
-5.583M
40.38%
-3.504M
40.91%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.42
6.67%
-0.41-0.01-1.82%
Q2 2024
Q2Q % growth
-0.51
-10.87%
-0.48-0.03-5.93%
Q1 2024
Q2Q % growth
-0.23
63.49%
-0.510.2855.05%
Q4 2023
Q2Q % growth
-0.53
-1.92%
-0.44-0.09-19.51%
Q3 2023
Q2Q % growth
-0.45
29.69%
-0.500.0510.29%
Q2 2023
Q2Q % growth
-0.46
41.77%
-0.540.0815.39%
Q1 2023
Q2Q % growth
-0.63
16.00%
-0.57-0.06-10.45%
Q4 2022
Q2Q % growth
-0.52
11.86%
-0.560.046.63%
Q3 2022
Q2Q % growth
-0.64
-12.28%
-0.640.00-0.31%
Q2 2022
Q2Q % growth
-0.79
-38.60%
-0.63-0.16-25.33%
Q1 2022
Q2Q % growth
-0.75
-33.93%
-0.57-0.18-31.89%
Q4 2021
Q2Q % growth
-0.59
-9.26%
-0.56-0.03-5.65%
Q3 2021
Q2Q % growth
-0.57
-7.55%
-0.54-0.03-6.44%
Q2 2021
Q2Q % growth
-0.57
-7.55%
-0.53-0.04-7.47%
Q1 2021
Q2Q % growth
-0.56
11.11%
-0.49-0.07-13.79%
Q4 2020
Q2Q % growth
-0.54
55.74%
-0.50-0.04-8.49%
Q3 2020
Q2Q % growth
-0.53
-2,550.00%
-0.50-0.03-7.03%
Q2 2020
Q2Q % growth
-0.53 -0.600.0711.56%
Q1 2020
Q2Q % growth
-0.63 -0.57-0.06-9.80%
Q4 2019
Q2Q % growth
-1.22 -0.61-0.61-101.02%
Q3 2019
Q2Q % growth
-0.02 -0.570.5596.50%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
18.957M
25.94%
19.229M-272K-1.41%
Q2 2024
Q2Q % growth
16.091M
11.02%
18.829M-2.738M-14.54%
Q1 2024
Q2Q % growth
16.603M
39.42%
16.645M-42K-0.25%
Q4 2023
Q2Q % growth
16.998M
46.28%
16.72M278K1.66%
Q3 2023
Q2Q % growth
15.052M
34.87%
16.52M-1.468M-8.89%
Q2 2023
Q2Q % growth
14.494M
39.23%
14.69M-196K-1.33%
Q1 2023
Q2Q % growth
11.909M
44.70%
12.259M-350K-2.86%
Q4 2022
Q2Q % growth
11.62M
38.83%
13.453M-1.833M-13.63%
Q3 2022
Q2Q % growth
11.16M
45.88%
11.082M78K0.70%
Q2 2022
Q2Q % growth
10.41M
37.70%
10.324M86K0.83%
Q1 2022
Q2Q % growth
8.23M
39.97%
8.112M118K1.45%
Q4 2021
Q2Q % growth
8.37M
47.62%
8.137M233K2.86%
Q3 2021
Q2Q % growth
7.65M
44.07%
7.698M-48K-0.62%
Q2 2021
Q2Q % growth
7.56M
115.38%
6.438M1.122M17.43%
Q1 2021
Q2Q % growth
5.88M
57.64%
5.565M315K5.66%
Q4 2020
Q2Q % growth
5.67M
16.67%
5.918M-248K-4.19%
Q3 2020
Q2Q % growth
5.31M
33.75%
4.67M640K13.70%
Q2 2020
Q2Q % growth
3.51M
6.36%
1.971M1.539M78.08%
Q1 2020
Q2Q % growth
3.73M
12.69%
3.74M-10K-0.27%
Q4 2019
Q2Q % growth
4.86M 4.263M597K14.00%
Q3 2019
Q2Q % growth
3.97M 4.016M-46K-1.15%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 41.06% 0% 6.42%
Revenue0% 9.71% 0% 0.42%